| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
-0.0062 |
0.9 |
| mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.0049 |
0.9 |
| mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
0.0048 |
0.9 |
| mRNA |
ATRA |
GDSC1000 |
pan-cancer |
AAC |
0.0052 |
0.9 |
| mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |
| mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.9 |
| mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.0043 |
0.9 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
| mRNA |
Dasatinib |
FIMM |
pan-cancer |
AAC |
0.025 |
0.9 |
| mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
-0.0048 |
0.9 |